VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
OPRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
OPRXOptimizeRx Corp.
$8.76$164M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksOPRXEarnings History

OPRX logoOptimizeRx Corp. (OPRX) Earnings History

Profitable

19 years of earnings data (2007–2025) · Positive TTM net income

TTM Net Income
$5M
● Profitable
TTM EPS (Diluted)
$0.24
Per share, diluted
YoY EPS Growth
+124.5%
Excellent
Net Margin
4.7%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin11.0%
Gross Margin63.3%
Return on Equity4.2%
Return on Assets2.9%
Record Annual Net Income$5MFY2025
Record Quarterly EPS$0.26Q4 2025
Consecutive Profitable Years1years
Q2 2026
Net Income-$703,000
EPS (Diluted)$-0.04
YoY Growth+124.5%Excellent
QoQ Growth-42.0%Declining

Loading earnings history...

OptimizeRx Corp. (OPRX) Earnings Overview

As of November 8, 2026, OptimizeRx Corp. (OPRX) reported trailing twelve-month net income of $5M, reflecting +124.5% year-over-year growth. The company earned $0.24 per diluted share over the past four quarters, with a net profit margin of 4.7%.

Looking at the long-term picture, OPRX's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2025, representing a new all-time high.

OptimizeRx Corp. maintains positive profitability with a gross margin of 63.3%, operating margin of 11.0%, and net margin of 4.7%. The company continues to generate positive earnings from operations. View revenue history →

Compared to peers including HCAT (-$202M net income, -57.2% margin), DOCS ($140M net income, 30.4% margin), PRVA ($35M net income, 1.1% margin), OPRX has outperformed on profitability metrics. Compare OPRX vs HCAT →

OPRX Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
OPRX logoOPRXCurrent
$5M$0.244.7%4.2%+124.5%—
HCAT logoHCAT
-$202M$-2.66-57.2%-58.3%-121.7%
DOCS logoDOCS
$140M$0.7430.4%19.3%-11.7%
PRVA logoPRVA
$35M$0.261.1%3.1%+63.6%
INVA logoINVA
$193M$2.6863.8%29.1%+816.7%
PGNY logoPGNY
$91M$1.124.5%12.5%+14.0%
Best in group
Lowest in group

OPRX Historical Earnings Data (2007–2025)

19 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$5M+125.5%$12M$0.274.7%11.0%
2024-$20M-14.5%-$14M$-1.10-21.8%-14.9%
2023-$18M-53.6%-$26M$-1.03-24.6%-36.9%
2022-$11M-3125.4%-$12M$-0.64-18.3%-19.7%
2021$378,079+117.1%$361,100$0.020.6%0.6%
2020-$2M+29.8%-$2M$-0.15-5.1%-4.9%
2019-$3M-1488.4%-$4M$-0.23-12.8%-15.0%
2018$226,344+110.8%$180,132$0.021.1%0.8%
2017-$2M-36.7%-$2M$-0.21-17.3%-17.6%
2016-$2M-158.6%-$2M$-0.16-19.9%-20.4%
2015$-595,140+42.0%$-597,407$-0.07-8.2%-8.3%
2014-$1M-575.1%-$1M$-0.14-15.8%-15.8%
2013$215,847+159.3%$215,601$-0.064.4%4.3%
2012$-363,976+82.8%$-364,345$-0.08-17.8%-17.8%
2011-$2M-5.6%-$1M$-0.46-190.8%-130.8%
2010-$2M+55.9%-$2M$-0.46-2827.0%-2597.9%
2009-$5M-7.2%-$3M$-1.09-17047.8%-9905.5%
2008-$4M-1075.5%-$2M$-1.06-5077.1%-1802.0%
2007$-361,466-$-355,941$-0.10-360.3%-354.8%

Download Data

Export OPRX earnings history in CSV or JSON format

Free sign-in required to download data

Consensus & Technical Research Suite
Open OPRX Terminal

OPRX Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

19+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

OPRX — Frequently Asked Questions

Quick answers to the most common questions about buying OPRX stock.

What is OPRX earnings per share (EPS)?

OPRX trailing twelve-month (TTM) diluted EPS is $0.24, reflecting +124.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2007 to 2025 is available in the table on this page.

What is OptimizeRx Corp.'s net income?

OptimizeRx Corp. (OPRX) trailing twelve-month net income is $5M as of 2025. Earnings grew +124.5% year-over-year.

Is OPRX profitable?

Yes, OPRX is profitable with a TTM net income of $5M and a net profit margin of +4.7%.

What is OPRX's earnings growth rate?

OPRX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2007 to 2025.

What are OPRX's profit margins?

OptimizeRx Corp. net profit margin is +4.7%, operating margin is +11.0%, and gross margin is +63.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is +4.2%.

Is OPRX growing earnings?

Yes, OPRX earnings are accelerating — EPS growth of +124.5% exceeds the 5-year CAGR of N/A. TTM net income reached $5M. Earnings momentum is strengthening.

What was OPRX's best earnings year?

OptimizeRx Corp.'s highest annual net income on record is $5M, achieved in fiscal year 2025. Earnings history on this page spans 2007 to 2025 and includes all annual and quarterly figures.

What were OPRX's earnings last quarter?

OPRX's most recent reported quarter was Q2 2026. Net income was $-703000.00 with diluted EPS of $-0.04. For a full breakdown of all quarters, see the quarterly earnings table on this page.

OPRX Earnings Over Time (2007–2025)

Net income & EPS — annual and quarterly view